Is FBRX or GALT more undervalued in 2026?

CirclFi compares Forte Biosciences, Inc. (FBRX) and Galectin Therapeutics Inc. (GALT) using 13 institutional-grade valuation models. FBRX has a Quality of Company score of 4.1/10 while GALT scores 3.7/10.

Which is a better buy — FBRX or GALT?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do FBRX and GALT valuations compare?

FBRX at $19.07 and GALT at $2.52 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

FBRX vs GALT Valuation Comparison 2026 — Intrinsic Value Analysis

FBRX

Pharmaceutical Preparations

Forte Biosciences, Inc.

Quality

4.1

out of 10

Value Trap

SAFE

Price

$19.07

Last close

Models

9/13

Active

GALT

Pharmaceutical Preparations

Galectin Therapeutics Inc.

Quality

3.7

out of 10

Value Trap

SAFE

Price

$2.52

Last close

Models

6/13

Active

Model-by-Model Comparison

Model	Type	FBRX Fair Value	FBRX Upside	GALT Fair Value	GALT Upside
Bayesian DCF	Intrinsic	$6.88	-63.9%	$0.71	-71.9%
Earnings Power Value	Intrinsic	$6.28	-77.7%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$20.13	+5.6%	$4.13	+63.9%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for FBRX vs GALT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

FBRX vs GALT — Which Stock Is More Undervalued?

FBRX scores higher with a 4.1/10 quality rating vs GALT's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Forte Biosciences, Inc. (FBRX) and Galectin Therapeutics Inc. (GALT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

FBRX currently trades at $19.07 with a QOC of 4.1/10, while GALT trades at $2.52 with a QOC of 3.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).